Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Incyte Corp.

Start price
Target price
Perf. (%)
€54.20
06.02.24
-
06.02.25
4.39%
05.08.24

William Blair 
06.02.24 50%
buy
STERIS plc

Start price
Target price
Perf. (%)
-
06.02.24
€235.72
06.02.25
-
-

KeyCorp 
06.02.24 50%
buy
Resmed Inc.

Start price
Target price
Perf. (%)
€178.25
06.02.24
€211.50
06.02.25
10.94%
05.08.24

KeyCorp 
06.02.24 50%
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€405.00
06.02.24
€425.79
06.02.25
7.51%
05.08.24

HC Wainwright 
06.02.24 50%
buy
Cigna Corp.

Start price
Target price
Perf. (%)
€299.10
05.02.24
€344.32
05.02.25
0.26%
05.08.24

Mizuho 
05.02.24 50%
buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€117.60
05.02.24
€125.66
05.02.25
-11.54%
05.08.24

Cantor Fitzgerald 
05.02.24 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€868.50
05.02.24
€1,034.6
05.02.25
12.63%
05.08.24

Royal Bank of Canada 
05.02.24 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€858.00
05.02.24
€1,006.8
05.02.25
14.01%
05.08.24

BMO Capital Markets 
05.02.24 50%
buy
AbbVie Inc.

Start price
Target price
Perf. (%)
€156.90
05.02.24
€181.45
05.02.25
8.17%
05.08.24

BMO Capital Markets 
05.02.24 50%
buy
Cigna Corp.

Start price
Target price
Perf. (%)
€306.30
05.02.24
€329.61
05.02.25
-2.10%
05.08.24

Royal Bank of Canada 
05.02.24 50%
buy
Cigna Corp.

Start price
Target price
Perf. (%)
€306.30
05.02.24
€346.37
05.02.25
-2.10%
05.08.24

Cantor Fitzgerald 
05.02.24 50%
buy
AbbVie Inc.

Start price
Target price
Perf. (%)
€157.40
05.02.24
€175.98
05.02.25
7.82%
05.08.24

Raymond James 
05.02.24 50%
buy
Becton, Dickinson & Co.

Start price
Target price
Perf. (%)
€220.50
05.02.24
€283.99
05.02.25
-1.56%
05.08.24

Barclays PLC 
05.02.24 50%
buy
AbbVie Inc.

Start price
Target price
Perf. (%)
€157.40
05.02.24
€172.25
05.02.25
7.82%
05.08.24

Barclays PLC 
05.02.24 50%
buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€117.00
03.02.24
-
03.02.25
-11.09%
05.08.24

StockNews.com 
03.02.24 50%
buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€43.44
02.02.24
-
-
03.02.24

Could be worthwhile Investment >10% per year
blaugold 
02.02.24 50%
buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€117.20
02.02.24
€128.74
02.02.25
-11.24%
05.08.24

Truist Financial Co. 
02.02.24 50%
buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€117.60
02.02.24
€137.06
02.02.25
-11.54%
05.08.24

UBS Group AG 
02.02.24 50%
buy
Hologic Inc.

Start price
Target price
Perf. (%)
€67.16
02.02.24
-
02.02.25
12.42%
05.08.24

William Blair 
02.02.24 50%
sell
Align Technology

Start price
Target price
Perf. (%)
€254.40
02.02.24
€208.24
02.02.25
-25.37%
05.08.24

The Goldman Sachs Group, Inc. 
02.02.24 50%
buy
Hologic Inc.

Start price
Target price
Perf. (%)
€67.16
02.02.24
€81.44
02.02.25
12.42%
05.08.24

Raymond James 
02.02.24 50%
buy
Edwards Lifesciences Corp.

Start price
Target price
Perf. (%)
€77.44
02.02.24
€87.14
02.02.25
-28.46%
05.08.24

Wells Fargo & Company 
02.02.24 50%
buy
Hologic Inc.

Start price
Target price
Perf. (%)
€66.96
02.02.24
€83.24
02.02.25
12.75%
05.08.24

Needham & Company LLC 
02.02.24 50%
buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€116.60
02.02.24
€134.11
02.02.25
-10.79%
05.08.24

Barclays PLC 
02.02.24 50%
buy
Boston Scientific

Start price
Target price
Perf. (%)
€59.64
01.02.24
€65.29
01.02.25
12.34%
05.08.24

Citigroup Inc. 
01.02.24 50%